Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion Summary-Reference-Cited by-同舟云学术

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion Summary

Published:2017-07 Issue:7 Volume:13 Page:459-461
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Virgo Katherine S.¹,Rumble R. Bryan¹,Singer Eric A.¹

Affiliation:

1. Emory University, Atlanta, GA; American Society of Clinical Oncology, Alexandria, VA; and Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2017.022970

Reference12 articles.

1. Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline

2. Natural History of Rising Serum Prostate-Specific Antigen in Men With Castrate Nonmetastatic Prostate Cancer

3. Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891

4. Clinical states in prostate cancer: toward a dynamic model of disease progression

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer;The Oncologist;2024-07-31

2. Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era;Cancer Medicine;2021-10-29

3. Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study;Japanese Journal of Clinical Oncology;2020-12-15

4. Effects of miR‑129‑3p on biological functions of prostate cancer cells through targeted regulation of Smad3;Oncology Letters;2019-12-13

5. High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer;Clinical Genitourinary Cancer;2019-12